Home LiteratureArticle Details
PMID: 7543533 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 155 ·No. 4 ·1995-08-15 ·Pages 1796-808

Okayama Y, Petit-Frére C, Kassel O, Semper A, Quint D, Tunon-de-Lara MJ, Bradding P, Holgate ST, Church MK

Abstract

By using the reverse transcriptase (RT)-PCR and in situ hybridization we have studied the expression of mRNA for IL-5 and IL-4 in human lung mast cells induced by cross-linkage of high affinity Fc epsilon Rs. Lung mast cells were purified using affinity magnetic selection with mAb YB5.B8 against c-kit to achieve a final mast cell purity > 93%. Purified mast cells were precultured with stem cell factor (SCF) (10 ng/ml) and myeloma IgE (3 micrograms/ml) for 16 h before challenge with anti-IgE (1 or 10 micrograms/ml). IgE-dependent activation of lung mast cells caused expression of IL-5 mRNA, which was evident by 2 h and persisted for up to 48-72 h in all of 12 experiments, whereas IL-4 mRNA expression was of a shorter duration and was demonstrable in 6 of 13 experiments. We confirmed that mast cells, and not T cells, were the source of these cytokine messages by using reverse transcriptase-PCR in cell preparations containing known numbers of mast cells and T cells, in situ hybridization in enriched mast cell preparations, and double in situ hybridization-immunocytochemical staining. IL-5 mRNA expression did not require the pretreatment of cells with SCF, whereas expression of IL-4 mRNA seemed to require both anti-IgE and SCF. The strength of IL-5 mRNA signal was related to anti-IgE concentration. Immunoreactive IL-5 was detectable 8 h after anti-IgE challenge, and 10(6) mast cells generated a mean of 731 +/- 400 pg of IL-5 into the supernatant during 48-h culture, but no IL-4 product was detectable. These findings demonstrate the capacity of human lung mast cells to transcribe IL-4 and IL-5 after IgE-dependent activation and to synthesize and release immunoreactive IL-5.

MeSH Terms
Base Sequence Cells, Cultured Hematopoietic Cell Growth Factors/pharmacology Humans Immunoglobulin E/physiology Interleukin-4/genetics Interleukin-5/genetics Lung/metabolism Mast Cells/metabolism Molecular Sequence Data RNA, Messenger/analysis Receptors, IgE/physiology Stem Cell Factor
Chemicals
Hematopoietic Cell Growth Factors Interleukin-5 RNA, Messenger Receptors, IgE Stem Cell Factor Interleukin-4 Immunoglobulin E
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Okayama Y
Immunopharmacology Group, Southampton General Hospital, United Kingdom.
Petit-Frére C
Kassel O
Semper A
Quint D
Tunon-de-Lara M J
Bradding P
Holgate S T
Church M K
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1995-08-15
Pages
1796-808
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com